Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Sci Rep ; 10(1): 12931, 2020 07 31.
Article in English | MEDLINE | ID: mdl-32737406

ABSTRACT

Despite the use of antiretroviral therapy (ART) in HIV-1 infected mothers approximately 5% of new HIV-1 infections still occur in breastfed infants annually, which warrants for the development of novel strategies to prevent new HIV-1 infections in infants. Human milk (HM) exosomes are highly enriched in microRNAs (miRNAs), which play an important role in neonatal immunity. Furthermore, HM exosomes from healthy donors are known to inhibit HIV-1 infection and transmission; however, the effect of HIV-1 on HM exosomal miRNA signatures remains unknown. In this study, we used nCounter NanoString technology and investigated miRNAs expression profiles in first week postpartum HM exosomes from HIV-1 infected and uninfected control mothers (n = 36). Our results indicated that HIV-1 perturbed the differential expression patterns of 19 miRNAs (13 upregulated and 6 downregulated) in HIV-1 infected women compared to healthy controls. DIANA-miR functional pathway analyses revealed that multiple biological pathways are involved including cell cycle, pathways in cancer, TGF-ß signaling, FoxO signaling, fatty acid biosynthesis, p53 signaling and apoptosis. Moreover, the receiver operating characteristics (ROC) curve analyses of miR-630 and miR-378g yielded areas under the ROC curves of 0.82 (95% CI 0.67 to 0.82) and 0.83 (95% CI 0.67 to 0.83), respectively highlighting their potential to serve as biomarkers to identify HIV-1 infection in women. These data may contribute to the development of new therapeutic strategies in prevention of mother-to-child transmission (MTCT) of HIV-1.


Subject(s)
Circulating MicroRNA/biosynthesis , Exosomes/metabolism , Gene Expression Regulation , HIV Infections/metabolism , HIV-1/metabolism , Milk, Human/metabolism , Adult , Circulating MicroRNA/genetics , Exosomes/genetics , Female , Gene Expression Profiling , HIV Infections/genetics , Humans , Mothers
2.
Front Immunol ; 10: 482, 2019.
Article in English | MEDLINE | ID: mdl-30930906

ABSTRACT

Toll-like receptors (TLRs) play a crucial role in innate immunity and provide a first line of host defense against invading pathogens. Of the identified human TLRs, TLR10 remains an orphan receptor whose ligands and functions are poorly understood. In the present study, we sought to evaluate the level of TLR10 expression in breast milk (BM) and explore its potential function in the context of HIV-1 infection. We evaluated HIV-1-infected (Nigerian: n = 40) and uninfected (Nigerian: n = 27; Canadian: n = 15) BM samples for TLR expression (i.e., TLR10, TLR2, and TLR1) and report here that HIV-1-infected BM from Nigerian women showed significantly higher levels of TLR10, TLR1, and TLR2 expression. Moreover, the level of TLR10 expression in HIV-1-infected BM was upregulated by over 100-fold compared to that from uninfected control women. In vitro studies using TZMbl cells demonstrated that TLR10 overexpression contributes to higher HIV-1 infection and proviral DNA integration. Conversely, TLR10 inhibition significantly decreased HIV-1 infection. Notably, HIV-1 gp41 was recognized as a TLR10 ligand, leading to the induction of IL-8 and NF-κBα activation. The identification of a TLR10 ligand and its involvement in HIV-1 infection enhances our current understanding of HIV-1 replication and may assist in the development of improved future therapeutic strategies.


Subject(s)
HIV Envelope Protein gp41/immunology , HIV Infections/immunology , HIV-1/immunology , Pregnancy Complications, Infectious/immunology , Toll-Like Receptor 10/immunology , Adult , Female , HIV Infections/pathology , Humans , Interleukin-8/immunology , Milk, Human/immunology , Pregnancy , Pregnancy Complications, Infectious/pathology , THP-1 Cells
3.
AIDS ; 32(16): 2383-2391, 2018 10 23.
Article in English | MEDLINE | ID: mdl-30134300

ABSTRACT

OBJECTIVE: The effects of in-utero HIV-exposure on infectious morbidity and mortality in settings with universal maternal treatment and high breastfeeding rates are unclear. Further, the benefits of exclusive feeding options have not been assessed in the Option B+ era. We investigated these in two African settings with high breastfeeding uptake and good HIV treatment infrastructure during the first year of life. METHODS: Cox regression with time-changing variables in a birth cohort of 749 HIV-exposed uninfected and HIV-unexposed uninfected infants from Cape Town, South Africa and Jos, Nigeria. RESULTS: There was no difference in infectious morbidity incidence between HIV-exposed uninfected and HIV-unexposed uninfected infants (hazard ratio 1.01; 95% CI 0.78-1.32) after adjusting for confounding variables. Formula-fed infants had significantly higher infectious morbidity incidence when compared with exclusively breastfed infants (hazard ratio 1.64; 95% CI 1.03-2.63) and mixed-breastfed infants (hazard ratio 1.42; 95% CI 1.00-2.02) after adjusting for potential confounding variables. There was no significant difference in mortality among HIV-exposed infants and HIV-unexposed infants during the first year of life in this cohort (2.04 versus 0.94%, P = 0.38). Notably, exclusive breastfeeding for only 4 months had protective effects on morbidity up to 1 year. CONCLUSION: In settings with universal antiretroviral coverage and high breastfeeding rates, breastfeeding mitigates the effects of in-utero HIV exposure among infants during the first year of life. These findings support previous recommendations for exclusive breastfeeding among HIV-infected women and highlight the role that breastfeeding plays on the health of infants in settings where exclusive breastfeeding is not always feasible or where replacement feeding is recommended.


Subject(s)
Breast Feeding , Communicable Diseases/epidemiology , Maternal Exposure , Adult , Female , Humans , Incidence , Infant , Infant, Newborn , Longitudinal Studies , Male , Nigeria/epidemiology , South Africa/epidemiology , Young Adult
4.
Front Immunol ; 8: 1631, 2017.
Article in English | MEDLINE | ID: mdl-29238342

ABSTRACT

The majority of infants' breastfeeding from their HIV-infected mothers do not acquire HIV-1 infection despite exposure to cell-free virus and cell-associated virus in HIV-infected breast milk. Paradoxically, exclusive breastfeeding regardless of the HIV status of the mother has led to a significant decrease in mother-to-child transmission (MTCT) compared with non-exclusive breastfeeding. Although it remains unclear how these HIV-exposed infants remain uninfected despite repeated and prolonged exposure to HIV-1, the low rate of transmission is suggestive of a multitude of protective, short-lived bioactive innate immune factors in breast milk. Indeed, recent studies of soluble factors in breast milk shed new light on mechanisms of neonatal HIV-1 protection. This review highlights the role and significance of innate immune factors in HIV-1 susceptibility and infection. Prevention of MTCT of HIV-1 is likely due to multiple factors, including innate immune factors such as lactoferrin and elafin among many others. In pursuing this field, our lab was the first to show that soluble toll-like receptor 2 (sTLR2) directly inhibits HIV infection, integration, and inflammation. More recently, we demonstrated that sTLR2 directly binds to selective HIV-1 proteins, including p17, gp41, and p24, leading to significantly reduced NFκB activation, interleukin-8 production, CCR5 expression, and HIV infection in a dose-dependent manner. Thus, a clearer understanding of soluble milk-derived innate factors with known antiviral functions may provide new therapeutic insights to reduce vertical HIV-1 transmission and will have important implications for protection against HIV-1 infection at other mucosal sites. Furthermore, innate bioactive factors identified in human milk may serve not only in protecting infants against infections and inflammation but also the elderly; thus, opening the door for novel innate immune therapeutics to protect newborns, infants, adults, and the elderly.

5.
AIDS ; 28(14): 2023-32, 2014 Sep 10.
Article in English | MEDLINE | ID: mdl-25265071

ABSTRACT

OBJECTIVES: We previously demonstrated that immunodepletion of soluble Toll-like receptor 2 (sTLR2) from human breast milk significantly increased HIV infection in vitro. The aims of this study were to characterize sTLR2 levels in breast milk from HIV-infected and uninfected women, and identify a mechanism by which sTLR2 inhibits HIV-induced cellular activation and infection. DESIGN: Blinded studies of breast milk from HIV-infected and uninfected Nigerian and Canadian women were evaluated for levels of sTLR2, proinflammatory cytokines and viral antigenemia. In-vitro experiments were conducted using cell lines to assess sTLR2 function in innate responses and effect on HIV infection. RESULTS: Breast milk from HIV-infected women showed significantly higher levels of sTLR2 than uninfected breast milk. Further, sTLR2 levels correlated with HIV-1 p24 and interleukin (IL)-15, thus suggesting a local innate compensatory response in the HIV-infected breast. Given the significantly higher levels of sTLR2 in breast milk from HIV-infected women, we next demonstrated that mammary epithelial cells and macrophages, which are prevalent in milk, produced significantly increased levels of sTLR2 following exposure to HIV-1 proteins p17, p24 and gp41 or the TLR2 ligand, Pam3CSK4. Our results also demonstrated that sTLR2 physically interacts with p17, p24 and gp41 and inhibits HIV-induced nuclear factor kappa-light-chain-enhancer of activated B cells activation, and inflammation. Importantly, binding of sTLR2 to HIV-1 proteins inhibited a TLR2-dependent increase in chemokine receptor 5 expression, thus resulting in significantly reduced HIV-1 infection. CONCLUSION: These results indicate novel mechanisms by which sTLR2 plays a critical role in inhibiting mother-to-child HIV transmission.


Subject(s)
Collagen Type XI/metabolism , HIV Infections/immunology , HIV-1/immunology , Immunity, Innate , Infectious Disease Transmission, Vertical/prevention & control , Milk, Human/immunology , Adult , Blotting, Western , Breast Feeding , Canada , Cell Line , Collagen Type XI/immunology , Female , HIV Infections/transmission , Humans , Infant, Newborn , Inflammation/immunology , Milk, Human/chemistry , Nigeria , Pregnancy , Tumor Necrosis Factor Receptor Superfamily, Member 7
6.
J Virol ; 87(13): 7526-38, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23637403

ABSTRACT

Serine protease inhibitor elafin (E) and its precursor, trappin-2 (Tr), have been associated with mucosal resistance to HIV-1 infection. We recently showed that Tr/E are among principal anti-HIV-1 molecules in cervicovaginal lavage (CVL) fluid, that E is ∼130 times more potent than Tr against HIV-1, and that Tr/E inhibited HIV-1 attachment and transcytosis across human genital epithelial cells (ECs). Since herpes simplex virus 2 (HSV-2) is a major sexually transmitted infection and risk factor for HIV-1 infection and transmission, we assessed Tr/E contribution to defense against HSV-2. Our in vitro studies demonstrated that pretreatment of endometrial (HEC-1A) and endocervical (End1/E6E7) ECs with human Tr-expressing adenovirus (Ad/Tr) or recombinant Tr/E proteins before or after HSV-2 infection resulted in significantly reduced virus titers compared to those of controls. Interestingly, E was ∼7 times more potent against HSV-2 infection than Tr. Conversely, knockdown of endogenous Tr/E by small interfering RNA (siRNA) significantly increased HSV-2 replication in genital ECs. Recombinant Tr and E reduced viral attachment to genital ECs by acting indirectly on cells. Further, lower viral replication was associated with reduced secretion of proinflammatory interleukin 8 (IL-8) and tumor necrosis factor alpha (TNF-α) and decreased NF-κB nuclear translocation. Additionally, protected Ad/Tr-treated ECs demonstrated enhanced interferon regulatory factor 3 (IRF3) nuclear translocation and increased antiviral IFN-ß in response to HSV-2. Lastly, in vivo studies of intravaginal HSV-2 infection in Tr-transgenic mice (Etg) showed that despite similar virus replication in the genital tract, Etg mice had reduced viral load and TNF-α in the central nervous system compared to controls. Collectively, this is the first experimental evidence highlighting anti-HSV-2 activity of Tr/E in female genital mucosa.


Subject(s)
Elafin/pharmacology , Epithelial Cells/virology , Herpes Genitalis/prevention & control , Herpesvirus 2, Human/drug effects , Viral Load/drug effects , Adenoviridae , Analysis of Variance , Animals , Blotting, Western , Cell Line, Tumor , Chlorocebus aethiops , DNA Primers/genetics , Elafin/genetics , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique , Gene Knockdown Techniques , Genetic Vectors/genetics , Humans , Interferon Regulatory Factor-3/metabolism , Interleukin-8/metabolism , Mice , Mice, Transgenic , NF-kappa B/metabolism , RNA Interference , RNA, Small Interfering/genetics , Real-Time Polymerase Chain Reaction , Tetrazolium Salts , Thiazoles , Tumor Necrosis Factor-alpha/metabolism , Vero Cells , Virus Attachment/drug effects , Virus Replication/drug effects
7.
PLoS One ; 7(7): e40138, 2012.
Article in English | MEDLINE | ID: mdl-22792230

ABSTRACT

The majority of infants who breastfeed from their HIV-positive mothers remain uninfected despite constant and repeated exposure to virus over weeks to years. This phenomenon is not fully understood but has been closely linked to innate factors in breast milk (BM). Most recently we have focused on one such innate factor, soluble Toll-like receptor 2 (sTLR2) for its significant contribution as an inhibitor of inflammation triggered by bacterial and viral antigens. We hypothesized that sTLR2 in BM inhibits immune activation/inflammation and HIV-1 infection. sTLR2 protein profiles were analyzed in HIV-uninfected BM and showed dramatic variability in expression concentration and predominant sTLR2 forms between women. sTLR2 immunodepleted BM, versus mock-depleted BM, incubated with Pam(3)CSK(4) lead to significant increases in IL-8 production in a TLR2-dependant fashion in U937, HEK293-TLR2, and Caco-2. Importantly, TLR2-specific polyclonal and monoclonal antibody addition to BM prior to cell-free R5 HIV-1 addition led to significantly (P<0.01, P<0.001, respectively) increased HIV-1 infection in TZM-bl reporter cells. To confirm these findings, sTLR2-depletion in BM led to significantly (P<0.001) increased HIV-1 infection in TZM-bl cells. Notably, immunodepletion does not allow for the complete removal of sTLR2 from BM, thus functional testing shown here may underestimate the total effect elicited by sTLR2 against HIV-1 and synthetic bacterial ligand. This study provides evidence for the first time that sTLR2 in BM may provide a dual protective role for infants breastfeeding from their HIV-infected mothers by; (1) immunomodulating pro-inflammatory responses to bacterial ligands, and (2) directly inhibiting cell-free HIV-1 infection. Thus, sTLR2 in BM may be critical to infant health and prove beneficial in decreasing vertical HIV-1 transmission to infants.


Subject(s)
HIV-1/immunology , Milk, Human/chemistry , Milk, Human/immunology , Toll-Like Receptor 2/immunology , Antibodies/blood , Antibodies/immunology , Antibody Specificity/immunology , Bacterial Proteins/immunology , Cell Line , Cytokines/immunology , Cytokines/metabolism , Female , HIV Infections/immunology , HIV Infections/transmission , Humans , Inflammation/immunology , Inflammation Mediators/immunology , Inflammation Mediators/metabolism , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Lipoproteins/immunology , Peptides/immunology , Toll-Like Receptor 2/chemistry , Toll-Like Receptor 2/metabolism
8.
PLoS One ; 7(4): e35866, 2012.
Article in English | MEDLINE | ID: mdl-22545145

ABSTRACT

BACKGROUND: Upon viral recognition, innate and adaptive antiviral immune responses are initiated by genital epithelial cells (ECs) to eradicate or contain viral infection. Such responses, however, are often accompanied by inflammation that contributes to acquisition and progression of sexually transmitted infections (STIs). Hence, interventions/factors enhancing antiviral protection while reducing inflammation may prove beneficial in controlling the spread of STIs. Serine antiprotease trappin-2 (Tr) and its cleaved form, elafin (E), are alarm antimicrobials secreted by multiple cells, including genital epithelia. METHODOLOGY AND PRINCIPAL FINDINGS: We investigated whether and how each Tr and E (Tr/E) contribute to antiviral defenses against a synthetic mimic of viral dsRNA, polyinosine-polycytidylic acid (polyI:C) and vesicular stomatitis virus. We show that delivery of a replication-deficient adenovector expressing Tr gene (Ad/Tr) to human endometrial epithelial cells, HEC-1A, resulted in secretion of functional Tr, whereas both Tr/E were detected in response to polyI:C. Moreover, Tr/E were found to significantly reduce viral replication by either acting directly on virus or through enhancing polyI:C-driven antiviral protection. The latter was associated with reduced levels of pro-inflammatory factors IL-8, IL-6, TNFα, lowered expression of RIG-I, MDA5 and attenuated NF-κB activation. Interestingly, enhanced polyI:C-driven antiviral protection of HEC-Ad/Tr cells was partially mediated through IRF3 activation, but not associated with higher induction of IFNß, suggesting multiple antiviral mechanisms of Tr/E and the involvement of alternative factors or pathways. CONCLUSIONS AND SIGNIFICANCE: This is the first evidence of both Tr/E altering viral binding/entry, innate recognition and mounting of antiviral and inflammatory responses in genital ECs that could have significant implications for homeostasis of the female genital tract.


Subject(s)
Elafin/immunology , Endometrium/cytology , Epithelial Cells/immunology , Epithelial Cells/virology , Immunity, Innate , RNA, Viral/immunology , Cell Line , Endometrium/immunology , Endometrium/virology , Female , Humans , Interferon Regulatory Factor-3/immunology , Interleukin-6/immunology , Interleukin-8/immunology , NF-kappa B/immunology , RNA, Viral/chemistry , Rhabdoviridae Infections/immunology , Rhabdoviridae Infections/virology , Vesiculovirus/immunology , Vesiculovirus/physiology , Virus Replication
9.
J Virol ; 86(8): 4599-610, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22345469

ABSTRACT

Cervicovaginal lavage fluid (CVL) is a natural source of anti-HIV-1 factors; however, molecular characterization of the anti-HIV-1 activity of CVL remains elusive. In this study, we confirmed that CVLs from HIV-1-resistant (HIV-R) compared to HIV-1-susceptible (HIV-S) commercial sex workers (CSWs) contain significantly larger amounts of serine antiprotease trappin-2 (Tr) and its processed form, elafin (E). We assessed anti-HIV-1 activity of CVLs of CSWs and recombinant E and Tr on genital epithelial cells (ECs) that possess (TZM-bl) or lack (HEC-1A) canonical HIV-1 receptors. Our results showed that immunodepletion of 30% of Tr/E from CVL accounted for up to 60% of total anti-HIV-1 activity of CVL. Knockdown of endogenous Tr/E in HEC-1A cells resulted in significantly increased shedding of infectious R5 and X4 HIV-1. Pretreatment of R5, but not X4 HIV-1, with either Tr or E led to inhibition of HIV-1 infection of TZM-bl cells. Interestingly, when either HIV-1 or cells lacking canonical HIV-1 receptors were pretreated with Tr or E, HIV-1 attachment and transcytosis were significantly reduced, and decreased attachment was not associated with altered expression of syndecan-1 or CXCR4. Determination of 50% inhibitory concentrations (IC(50)) of Tr and E anti-HIV-1 activity indicated that E is ∼130 times more potent than its precursor, Tr, despite their equipotent antiprotease activities. This study provides the first experimental evidence that (i) Tr and E are among the principal anti-HIV-1 molecules of CVL; (ii) Tr and E affect cell attachment and transcytosis of HIV-1; (iii) E is more efficient than Tr regarding anti-HIV-1 activity; and (iv) the anti-HIV-1 effect of Tr and E is contextual.


Subject(s)
Anti-HIV Agents/pharmacology , Elafin/pharmacology , Genitalia, Female/virology , HIV-1/drug effects , Anti-HIV Agents/metabolism , CD4 Antigens/metabolism , Cell Line , Elafin/genetics , Elafin/metabolism , Epithelial Cells/immunology , Female , Gene Silencing , Genitalia, Female/immunology , Genitalia, Female/metabolism , HIV-1/immunology , Humans , Immunity, Mucosal , Leukocyte Elastase/antagonists & inhibitors , RNA, Small Interfering/metabolism , Receptors, CXCR5/metabolism , Transcytosis/drug effects , Virus Attachment/drug effects
10.
PLoS One ; 7(12): e52738, 2012.
Article in English | MEDLINE | ID: mdl-23300756

ABSTRACT

Elafin (E) and its precursor trappin-2 (Tr) are alarm antiproteases with antimicrobial and immunomodulatory activities. Tr and E (Tr/E) have been associated with HIV-1 resistance. We recently showed that Tr/E reduced IL-8 secretion and NF-κB activation in response to a mimic of viral dsRNA and contributed to anti-HIV activity of cervicovaginal lavage fluid (CVL) of HIV-resistant (HIV-R) commercial sex workers (CSWs). Additionally, Tr, and more so E, were found to inhibit attachment/entry and transcytosis of HIV-1 in human endometrial HEC-1A cells, acting through virus or cells. Given their immunomodulatory activity, we hypothesized that Tr/E could exert anti-HIV-1 activity at multiple levels. Here, using tagged and untagged Tr/E proteins, we comparatively evaluated their protease inhibitory, anti-HIV-1, and immunomodulatory activities, and cellular distribution. E appeared to function as an autocrine/paracrine factor in HEC-1A cells, and anti-HIV-1 activity of E depended on its unmodified N-terminus and altered cellular innate activation, but not its antiprotease activity. Specifically, exogenously added N-terminus-unmodified E was able to enter the nucleus and to reduce viral attachment/entry and transcytosis, preferentially affecting R5-HIV-1(ADA), but not X4-HIV-1(IIIB). Further, anti-HIV-1 activity of E was associated with significantly decreased HIV-1-triggered IL-8 release, attenuated NF-κB/p65 nuclear translocation, and significantly modulated mRNA expression of innate sensors TLR3 and RIG-I in HEC-1A cells. Most importantly, we found that elevated Tr/E in CVLs of HIV-R CSWs were associated with lower mRNA levels of TLRs 2, 3, 4 and RIG-I in the genital ECs from this cohort, suggesting a link between Tr/E, HIV-1 resistance and modulated innate viral recognition in the female genital mucosa. Collectively, our data indicate that unmodified N-terminus is critical for intranuclear localization and anti-HIV-1 activity of E. We also propose that E-mediated altered cellular innate activation most likely contributes to the HIV-R phenotype of these subjects.


Subject(s)
Cell Nucleus/metabolism , Elafin/physiology , Epithelial Cells/drug effects , HIV-1/physiology , Immunity, Innate , Cell Line, Tumor , Cervix Uteri/cytology , DEAD Box Protein 58 , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/metabolism , Disease Resistance , Epithelial Cells/immunology , Epithelial Cells/metabolism , Epithelial Cells/virology , Female , Gene Expression Regulation , HIV-1/immunology , Host-Pathogen Interactions , Humans , Interleukin-8/metabolism , NF-kappa B/metabolism , Protein Structure, Tertiary , Protein Transport , Receptors, Immunologic , Receptors, Pattern Recognition/genetics , Receptors, Pattern Recognition/metabolism , Sex Workers , Toll-Like Receptor 3/genetics , Toll-Like Receptor 3/metabolism , Transcytosis , Tumor Necrosis Factor-alpha , Virus Attachment , Virus Internalization
11.
Biochem Soc Trans ; 39(5): 1427-32, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21936827

ABSTRACT

Despite tremendous advances in our understanding of HIV/AIDS since the first cases were reported 30 years ago, we are still a long way from understanding critical steps of HIV acquisition, pathogenesis and correlates of protection. Our new understanding of the importance of the mucosa as a target for HIV infection, as well as our recent observations showing that altered expression and responses of innate pattern recognition receptors are significantly associated with pathogenesis and resistance to HIV infection, indicate that correlates of immunity to HIV are more likely to be associated with mucosal and innate responses. Most of the heterosexual encounters do not result in productive HIV infection, suggesting that the female genital tract is protected against HIV by innate defence molecules, such as antiproteases, secreted mucosally. The present review highlights the role and significance of the serine protease inhibitors SLPI (secretory leucocyte protease inhibitor), trappin-2, elafin and ps20 (prostate stromal protein 20 kDa) in HIV susceptibility and infection. Interestingly, in contrast with SLPI, trappin-2 and elafin, ps20 has been shown to enhance HIV infectivity. Thus understanding the balance and interaction of these factors in mucosal fluids may significantly influence HIV infection.


Subject(s)
Elafin/immunology , HIV Infections/immunology , HIV/immunology , Milk Proteins/immunology , Proteins/immunology , Secretory Leukocyte Peptidase Inhibitor/immunology , Female , Genitalia, Female/immunology , Humans , Immunity, Mucosal/immunology , Protease Inhibitors/immunology
12.
Cancer Res ; 71(7): 2497-506, 2011 Apr 01.
Article in English | MEDLINE | ID: mdl-21307131

ABSTRACT

There is increasing evidence that natural killer (NK) cells play an important role in antitumor immunity following dendritic cell (DC) vaccination. Little is known, however, about the optimal stimulation of DCs that favors NK activation in tumor-bearing hosts. In this study, we demonstrate that treatment with toll-like receptor (TLR) ligands and infection with a mutant vesicular stomatitis virus (VSV-ΔM51) both induced DC maturation. Further, inoculation of these DCs led to robust NK-mediated protection against tumor challenge. Strikingly, only VSV-ΔM51-infected DCs were capable of suppressing the growth of established tumors, suggesting that additional signals provided by viral infection may be required to activate tumoricidal NK cells in tumor-bearing hosts. VSV-ΔM51 infection of DCs induced greater type I interferon (IFN I) production than TLR ligand treatment, and disruption of the IFN I pathway in DCs eliminated their ability to induce NK activation and tumor protection. However, further studies indicated that IFN I alone was not sufficient to activate NK cells, especially in the presence of a tumor, and DC-derived IL-15 was additionally required for tumoricidal NK activation. These results suggest that induction of IFN I by VSV-ΔM51 allows DCs to overcome tumor-associated immunosuppression and facilitate IL-15-mediated priming of tumoricidal NK cells. Thus, the mode of DC maturation should be carefully considered when designing DC-based cancer immunotherapies.


Subject(s)
Dendritic Cells/immunology , Dendritic Cells/virology , Immunotherapy, Adoptive/methods , Interleukin-15/immunology , Killer Cells, Natural/immunology , Melanoma, Experimental/therapy , Vesiculovirus/immunology , Animals , Cancer Vaccines/immunology , Female , Interferon Regulatory Factor-3/immunology , Interferon Regulatory Factor-3/metabolism , Interferon Type I , Ligands , Melanoma, Experimental/immunology , Mice , Mice, Inbred C57BL , Signal Transduction , Toll-Like Receptors/immunology , Toll-Like Receptors/metabolism
13.
J Reprod Immunol ; 87(1-2): 39-44, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20688399

ABSTRACT

Although the female genital tract is the main portal of entry for sexually transmitted infections in women, we still have limited understanding of the generation, maintenance and characteristics of memory T cells in the local tissue. Here, we utilized a mouse model of intravaginal HSV-2 infection and tetramers against the immunodominant HSV glycoprotein B epitope recognized by CD8+ T cells to examine the generation, maintenance and characteristics of anti-HSV memory T cells in the genital tract following acute infection. Our results show that the highest percentage of HSVgB-specific CD8+ T cells was found in the genital tract compared to the spleen or iliac lymphnode. Indeed, although the actual number of CD8+ T cells contracted following viral clearance, approximately one quarter of the CD8+ population that remained in the genital tissue was HSVgB-specific. Memory gB-tetramer+CD8 T cells in the genital tract were positive for CD127 and KLRG1 and negative for CD62L and CCR7, thus confirming that HSV-specific CD8 cells were effector memory T cells that lack the capacity for homing to lymphoid tissues. Functionally, both memory CD8+ and CD4+ HSV-specific populations in the genital tract produced IFNγ when stimulated in vitro and CD4+ cells also produced TNFα. Genital HSVgB-specific memory T cells expressed tissue-homing integrins CD103 (αE integrin) and CD49a (VLA-1 or α1 integrin). Our findings suggest that HSV-specific memory T cells are retained in the genital tract, poised to act as an early line of defense against future virus encounter.


Subject(s)
Genitalia, Female/immunology , Herpes Genitalis/immunology , Herpesvirus 2, Human/immunology , Immunologic Memory , T-Lymphocytes/immunology , Viral Envelope Proteins/immunology , Animals , Antigens, CD/biosynthesis , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Female , Flow Cytometry , Genitalia, Female/virology , Herpes Genitalis/virology , Integrin alpha Chains/biosynthesis , Integrin alpha1/biosynthesis , Interferon-gamma/biosynthesis , Interleukin-7 Receptor alpha Subunit/metabolism , Lectins, C-Type/metabolism , Mice , Mice, Inbred C57BL , Receptors, Immunologic , Spleen/immunology , T-Lymphocytes/metabolism , Trans-Activators/metabolism , Tumor Necrosis Factor-alpha/biosynthesis
14.
Vaccine ; 28(43): 7070-80, 2010 Oct 08.
Article in English | MEDLINE | ID: mdl-20723627

ABSTRACT

Induction of neutralizing antibodies to prevent HIV infection, especially at the mucosa, is a critical goal of future vaccines. In this study, we have designed chimeric HIV-gag virus-like particles (VLPs) that contain multiple copies of the two highly conserved gp41 membrane-proximal external region (MPER) epitopes, ELDKWA and NWFDIT, with the objective of generating high titers of MPER-specific antibodies. We have shown that the implementation of optimized vector design, delivery regimens and appropriate delivery methods is critical to significantly increase epitope-specific antibody titers. One goal of the methods that were tested and employed was to generate high levels of mucosal MPER-specific antibodies, as mucosal immune induction could play a key role in preventing HIV infection. We also tested a design strategy that incorporated multiple repeats of the MPER epitopes within gag, which significantly increased specific antibody titers, systemically and mucosally. This alternative design strategy and the implementation of optimized heterologous immunization regimens can serve to 'immuno-focus' and significantly increase epitope-specific titers.


Subject(s)
AIDS Vaccines/immunology , HIV Antibodies/immunology , HIV Envelope Protein gp41/immunology , HIV Infections/prevention & control , Vaccines, Virus-Like Particle/immunology , Adenoviridae/immunology , Administration, Intranasal , Animals , Antibodies, Neutralizing/immunology , CpG Islands , Epitopes/immunology , Female , Genetic Vectors , HIV Infections/immunology , Immunity, Mucosal , Immunization/methods , Immunization, Secondary , Mice , Mice, Inbred C57BL , Neutralization Tests , Tandem Repeat Sequences , Vaccines, DNA/immunology
15.
PLoS One ; 4(12): e8379, 2009 Dec 21.
Article in English | MEDLINE | ID: mdl-20027308

ABSTRACT

Studies of human NK cells and their role in tumor suppression have largely been restricted to in vitro experiments which lack the complexity of whole organisms, or mouse models which differ significantly from humans. In this study we showed that, in contrast to C57BL/6 Rag2(-/-)/gamma(c) (-/-) and NOD/Scid mice, newborn BALB/c Rag2(-/-)/gamma(c) (-/-) mice can support the development of human NK cells and CD56+ T cells after intrahepatic injection with hematopoietic stem cells. The human CD56(+) cells in BALB/c Rag2(-/-)/gamma(c) (-/-) mice were able to produce IFN-gamma in response to human IL-15 and polyI:C. NK cells from reconstituted Rag2(-/-)/gamma(c) (-/-) mice were also able to kill and inhibit the growth of K562 cells in vitro and were able to produce IFN-gamma in response to stimulation with K562 cells. In vivo, reconstituted Rag2(-/-)/gamma(c) (-/-) mice had higher survival rates after K562 challenge compared to non-reconstituted Rag2(-/-)/gamma(c) (-/-) mice and were able to control tumor burden in various organs. Reconstituted Rag2(-/-)/gamma(c) (-/-) mice represent a model in which functional human NK and CD56+ T cells can develop from stem cells and can thus be used to study human disease in a more clinically relevant environment.


Subject(s)
Immunocompromised Host/immunology , Killer Cells, Natural/cytology , Killer Cells, Natural/transplantation , Neoplasms/immunology , Neoplasms/prevention & control , Animals , Body Weight , CD56 Antigen/metabolism , Cell Degranulation , Cell Proliferation , Cytotoxicity, Immunologic , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/metabolism , Humans , Injections , Interferon-gamma/biosynthesis , Interleukin Receptor Common gamma Subunit/deficiency , Interleukin Receptor Common gamma Subunit/metabolism , K562 Cells , Killer Cells, Natural/physiology , Mice , Mice, Inbred Strains , Models, Animal , Neoplasms/pathology , Survival Analysis , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/transplantation , Tumor Burden/immunology
16.
J Virol ; 83(20): 10664-76, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19656896

ABSTRACT

Genital herpes, caused by herpes simplex virus type 2 (HSV-2), is one of the most prevalent sexually transmitted diseases worldwide and a risk factor for acquiring human immunodeficiency virus. Although many vaccine candidates have shown promising results in animal models, they have failed to be effective in human trials. In this study, a humanized mouse strain was evaluated as a potential preclinical model for studying human immune responses to HSV-2 infection and vaccination. Immunodeficient mouse strains were examined for their abilities to develop human innate and adaptive immune cells after transplantation of human umbilical cord stem cells. A RAG2(-/-) gammac(-/-) mouse strain with a BALB/c background was chosen as the most appropriate model and was then examined for its ability to mount innate and adaptive immune responses to intravaginal HSV-2 infection and immunization. After primary infection, human cells in the lymph nodes were able to generate a protective innate immune response and produce gamma interferon (IFN-gamma). After intravaginal immunization and infection, human T cells and NK cells were found in the genital tract and iliac lymph nodes. In addition, human T cells in the spleen, lymph nodes, and vaginal tract were able to respond to stimulation with HSV-2 antigens by replicating and producing IFN-gamma. Human B cells were also able to produce HSV-2-specific immunoglobulin G. These adaptive responses were also shown to be protective and reduce local viral replication in the genital tract. This approach provides a means for studying human immune responses in vivo using a small-animal model and may become an important preclinical tool.


Subject(s)
Disease Models, Animal , Herpes Genitalis/immunology , Herpesvirus 2, Human/pathogenicity , Administration, Intravaginal , Animals , Antibodies, Viral/blood , Herpes Genitalis/prevention & control , Herpes Genitalis/virology , Herpes Simplex Virus Vaccines/administration & dosage , Herpes Simplex Virus Vaccines/immunology , Humans , Immunity, Innate , Immunity, Mucosal , Immunization , Killer Cells, Natural/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Mice, SCID , Stem Cell Transplantation , T-Lymphocytes/immunology , Umbilical Cord
17.
PLoS One ; 4(5): e5644, 2009 May 21.
Article in English | MEDLINE | ID: mdl-19461969

ABSTRACT

BACKGROUND: Subclinical endotoxemia has been reported in HIV-1 infected persons and may drive systemic immune activation and pathogenesis. Proinflammatory responsiveness to endotoxin (LPS) is mediated by Toll-like receptor 4 (TLR4). We therefore examined the association between plasma LPS levels, HIV RNA, and TLR4 expression and cytokine responses in the blood of HIV infected and uninfected participants in a cohort of female sex-workers in Kenya. METHODOLOGY/PRINCIPAL FINDINGS: Ex vivo plasma and peripheral blood mononuclear cells (PBMC) were assessed for LPS and TLR mRNA, respectively. The effects of HIV single stranded RNA, a TLR8 ligand, on TLR4 and LPS signaling were further assessed in short term PBMC culture. Both HIV uninfected and infected subjects frequently had low detectable LPS levels in their plasmas. Significantly increased LPS levels were associated with chronic HIV-1 infection, both treated and untreated, but not with other acute or semi-chronic conditions reported. In HIV-uninfected subjects, TLR4 mRNA expression levels correlated inversely with plasma LPS levels, suggesting chronic endotoxin 'tolerance' in vivo. A similar effect of reduced TLR4 mRNA was seen in short term PBMC culture after stimulation with LPS. Interestingly, the apparent in vivo tolerance effect was diminished in subjects with HIV infection. Additionally, pre-stimulation of PBMC with LPS lead to proinflammatory (TNF-alpha) tolerance to subsequent LPS stimulation; however, pre-treatment of PBMC with HIV single-stranded RNA40, could enhance TLR4-mediated LPS responsiveness in vitro. CONCLUSIONS/SIGNIFICANCE: Thus, dysregulation of endotoxin tolerance by HIV-1 RNA may exacerbate HIV chronic immune activation and pathogenesis.


Subject(s)
Endotoxemia/immunology , HIV-1/immunology , RNA, Viral/immunology , Sex Work , Toll-Like Receptors/immunology , Adult , Cytokines/metabolism , Endotoxemia/blood , Female , Gene Expression Regulation , HIV Infections/blood , Humans , Immune Tolerance/immunology , Kenya , Lipopolysaccharides/blood , Lymphocytes/metabolism , Middle Aged , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism
18.
Antiviral Res ; 81(2): 103-12, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19013198

ABSTRACT

Genital epithelial cells (GECs) are the first line of mucosal defense against sexually transmitted infections. We exploited the ability of GECs to mount innate immune responses, by using TLR ligands to induce anti-viral activity against Herpes simplex virus, type 2 (HSV-2). Primary cultures of GECs were grown to confluent, polarized monolayers and found to express different levels of mRNA for TLR1-10. Innate anti-viral responses against HSV-2 infection were determined following treatment with eight different TLR ligands. HSV-2 replication was significantly inhibited following treatment with ligands for TLR3, 5 and 9, while lipo-polysaccharide (LPS), a TLR4 ligand, failed to provide any protection. Biologically active interferon-beta and nitric oxide production by GECs correlated with anti-viral activity. Following treatment with TLR3 ligand Poly I:C, inflammatory cytokines were upregulated. Poly I:C treatment led to activation of downstream transcription factors including interferon regulatory factor-3 (IRF-3) and NFkappaB. Anti-viral responses induced by TLR ligands in GECs may provide a unique alternative to topical microbicides by enhancing body's own mucosal innate defense mechanisms against sexually transmitted viruses.


Subject(s)
Epithelial Cells/immunology , Epithelial Cells/virology , Herpesvirus 2, Human/immunology , Toll-Like Receptors/immunology , Adult , Cells, Cultured , Female , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Interferon-beta/biosynthesis , Interferon-beta/immunology , Middle Aged , Nitric Oxide/biosynthesis , Nitric Oxide/immunology , Virus Replication/immunology
19.
AIDS ; 22(6): 685-94, 2008 Mar 30.
Article in English | MEDLINE | ID: mdl-18356597

ABSTRACT

OBJECTIVES: Toll-like receptors (TLR) are important in pathogen recognition and may play a role in HIV disease. We evaluated the effect of chronic untreated and treated HIV-1 infection on systemic TLR expression and TLR signalling. METHODS: Two hundred HIV-infected and uninfected women from a Kenya cohort participated in the studies. TLR1 to TLR10 messenger RNA expression was determined by quantitative reverse transcriptase polymerase chain reaction in peripheral blood mononuclear cells (PBMC). TLR ligand responsiveness was determined in or using ex-vivo PBMC by cytokine production in culture supernatants. RESULTS: Chronic, untreated HIV-1 infection was significantly associated with increased mRNA expression of TLR6, TLR7, and TLR8 and when analysis was limited to those with advanced disease (CD4 cell count < 200 cells/ml) TLR2, TLR3, and TLR4 were additionally elevated. TLR expression correlated with the plasma HIV-RNA load, which was significant for TLR6 and TLR7. In vitro HIV single-stranded RNA alone could enhance TLR mRNA expression. PBMC of HIV-infected subjects also demonstrated profoundly increased proinflammatory responsiveness to TLR ligands, suggesting sensitization of TLR signalling in HIV. Finally, viral suppression by HAART was associated with a normalization of TLR levels. CONCLUSION: Together, these data indicate that chronic viraemic HIV-1 is associated with increased TLR expression and responsiveness, which may perpetuate innate immune dysfunction and activation that underlies HIV pathogenesis, and thus reveal potential new targets for therapy.


Subject(s)
HIV Infections/metabolism , HIV-1 , Toll-Like Receptors/blood , Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , Case-Control Studies , Female , HIV Infections/drug therapy , HIV Infections/immunology , Humans , Kenya , Ligands , Lymphocyte Activation , Lymphocyte Count , RNA, Messenger/analysis , RNA, Viral/pharmacology , Reverse Transcriptase Polymerase Chain Reaction/methods , Toll-Like Receptor 2/blood , Toll-Like Receptor 3/blood , Toll-Like Receptor 4/blood , Toll-Like Receptor 6/blood , Toll-Like Receptor 7/blood , Toll-Like Receptor 8/blood , Toll-Like Receptors/metabolism , Viral Load , Viremia/immunology
20.
Biol Reprod ; 77(6): 1049-59, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17881767

ABSTRACT

Genital epithelial cells (ECs) are the first line of defense that sexually transmitted viruses encounter. The mechanism of viral pathogenesis in these cells is not well understood. Here, we show that a primary cell culture model from human reproductive tract tissues can be used as a novel ex vivo model in examining the interaction of herpes simplex virus, type 2 (HSV-2), with female genital mucosa. Confluent, polarized primary cultures of human endometrial and cervical ECs were established and shown to be free from any significant contamination of any other cell type. Both endometrial and cervical ECs were found to be highly susceptible to HSV-2 infection. The kinetic of infection was similar to in vivo infection, with the earliest viral shedding seen at 18 h postinfection. Primary EC monolayers could be infected both apically and basolaterally, but preferential viral shedding was seen on the apical side of cells. Following treatment of the monolayers with poly (I:C), an innate immune activator that acts via TLR3, viral shedding was reduced significantly, comparable to levels seen when an antiviral formulation, acyclovir, was used. Treatment of epithelial and stromal co-cultures with estradiol increased HSV-2 infection in endometrial ECs, but viral shedding decreased following treatment with progesterone. To the best of our knowledge, this is the first study that examines the interaction of primary human female genital ECs with HSV-2, using an ex vivo culture model. The results provide valuable information regarding the susceptibility of women's genital ECs to HSV-2 and the ability of innate immunity and hormones to modify this susceptibility.


Subject(s)
Cervix Uteri/virology , Endometrium/virology , Epithelial Cells/virology , Herpes Genitalis/virology , Herpesvirus 2, Human/physiology , Antiviral Agents/pharmacology , Cells, Cultured , Epithelial Cells/drug effects , Estradiol/pharmacology , Female , Herpesvirus 2, Human/drug effects , Host-Pathogen Interactions/physiology , Humans , Poly I-C/pharmacology , Progesterone/pharmacology , Stromal Cells/virology , Toll-Like Receptor 3/agonists
SELECTION OF CITATIONS
SEARCH DETAIL
...